Dr. Lev Verkh

Dr. Verkh has directed national and multi-national Phase I, II, III and IV clinical trials in such areas as

cardiology, oncology, neurology, peripheral vascular

diseases, hematology, blood disorders and imaging

methods. Through his efforts and the efforts of his

teams, he has received FDA approval for several products

that are currently on the market. Under his leadership,

Stemedica obtained several INDs for clinical trials in

the United States and emergency INDs from the FDA.